← Back to Search

Portable Driving Simulator for Neurological Conditions

N/A

Recruiting

Led By Abiodun Akinwuntan, PhD, MPH MBA

Research Sponsored by University of Kansas Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of a first ever stroke, PD, or MS

Be older than 18 years old

Must not have

Diagnosis of traumatic brain injury or any other neurological condition apart from stroke, PD, and MS.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up assessed during visit 1, visit 2, visit 3, visit 4, and visit 5. these visits will take place over an average of one week.

Awards & highlights

No Placebo-Only Group

Summary

This trialwill explore the efficacy of a low-cost, low-fidelity, portable driving simulator to retrain driving skills of stroke survivors, Parkinson's and MS patients.

Who is the study for?

This trial is for individuals with a first-ever stroke, Parkinson's disease (PD), or multiple sclerosis (MS) who have valid driver's licenses and at least 3 years of driving experience. They must score ≥24 on the Mini-mental State Examination and have binocular acuity meeting Kansas driving laws.

What is being tested?

The study compares a low-cost portable driving simulator (PDS) to a high-fidelity fixed-base simulator in retraining driving skills. Participants will be randomly assigned to one of these tools for training and evaluated before and after the sessions.

What are the potential side effects?

Potential side effects may include simulator sickness, which is less expected with the PDS due to its simpler setup compared to the high-fidelity simulator.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with stroke, Parkinson's disease, or multiple sclerosis for the first time.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a brain injury or another neurological condition, but not stroke, Parkinson's, or MS.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ assessed during visit 1, visit 2, visit 3, visit 4, and visit 5. these visits will take place over an average of one week.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~assessed during visit 1, visit 2, visit 3, visit 4, and visit 5. these visits will take place over an average of one week.

This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed during visit 1, visit 2, visit 3, visit 4, and visit 5. these visits will take place over an average of one week. for reporting.